Ishana Harkoo

机构：Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal

发表论文 26 篇 · 总被引 883 次 · h-index 10

代表论文

• Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (2024 · New England Journal of Medicine · 被引 473)
• Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study (2021 · The Lancet HIV · 被引 111)
• Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial (2023 · The Lancet HIV · 被引 42)
• Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (2022 · The Journal of Infectious Diseases · 被引 37)
• Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial (2021 · AIDS and Behavior · 被引 37)
• CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women (2022 · BMJ Open · 被引 35)